"Studies have concluded that the use of PillCam SB in patients with inflammatory bowel disease, such as Crohn's disease, frequently changes the diagnosis, often resulting in a change in patient therapy, thereby underscoring the clinical impact of this tool."
- Blair Lewis, MD, Clinical Professor of Medicine, Mount Sinai Medical Center, New York
Visualizing the Entire Small Bowel
PillCam SB was initially cleared by the U.S. Food and Drug Administration (FDA) in 2001. The vitamin-sized capsule provides a way to visualize, monitor and diagnose small bowel abnormalities including abnormalities associated with obscure GI bleeding (OGIB), iron deficiency anemia (IDA) and Crohn’s disease. This patient-friendly tool has been validated by more than 1,600 peer-reviewed studies.
PillCam SB captures a broad mucosal area per image with a 156° field-of-view at 4.5 mm working distance. In addition, advanced optics and Automatic Light Control provide optimal image quality and illumination.